Marion Kiechle - Concepedia

Author

Marion Kiechle

Also Known As

A Schnelzer, Alfons Meindl, Barendorf Jarmatz, Benedetta Zampa, Kiechle, M., Kiechle, Marion, M Kiechle, M. Kiechle, M. Kiechle, MARION KIECHLE

666

Publications

10.5K

Citations

H-Index

140

Concepts

All Affiliations

Technical University of Munich Klinikum rechts der Isar Ludwig-Maximilians-Universität München Heidelberg University Heinrich Heine University Düsseldorf

About

Marion Kiechle is an author at Technical University of Munich specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	62	4.1K
2	Health Sciences	8	8	777
3	Engineering	7	7	697
4	Nursing	3	3	60
5	Natural Sciences	2	2	50

Marion Kiechle

163

Publications

9.1K

Citations

H-Index

Page 1

	Year	Citations
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene Alfons Meindl, Heide Hellebrand, Constanze Wiek, Nature Genetics Breast OncologySomatic VariantCancer PathologyOvarian Cancer PedigreesGenetics	2010	727
Contralateral Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Monika Graeser, Christoph Engel, Kerstin Rhiem, Journal of Clinical Oncology	2009	309
CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer Holger Bronger, J. David Singer, Claudia Windmüller, British Journal of Cancer	2016	257
Prevalence of <i>BRCA1/2</i> germline mutations in 21 401 families with breast and ovarian cancer Karin Kast, Kerstin Rhiem, Barbara Wappenschmidt, Journal of Medical Genetics	2016	217
Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424). Nadia Harbeck, Ronald Kates, Maxime P. Look, PubMed Breast OncologyBreast Cancer PatientsMedicineCancer ManagementPharmacology	2002	193
A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC Norbert Arnold, J. Goette, Ulrike Schwarz‐Boeger, Human Genetics EngineeringSomatic VariantDirect SequencingBrca1 Mutation AnalysisGenetics	1999	173
First demonstration of 3-D lymphatic mapping in breast cancer using freehand SPECT Thomas Wendler, Ken Herrmann, Andreas Schnelzer, European Journal of Nuclear Medicine and Molecular Imaging Medical ImagingBiomedical ImagingLymphatic SystemBreast ImagingBreast Cancer	2010	171
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients Nadia Harbeck, Manfred Schmitt, Christoph Meisner, European Journal of Cancer Ten-year AnalysisBreast OncologyMedicineClinical OncologyBreast Cancer	2013	163
Large scale multifactorial likelihood quantitative analysis of <i>BRCA1</i> and <i>BRCA2</i> variants: An ENIGMA resource to support clinical variant classification Michael T. Parsons, Emma Tudini, Hongyan Li, Human Mutation GeneticsGenetic EpidemiologyPathologyMultifactorial Likelihood AnalysisDisease Gene Identification	2019	148
Validation of the German version of the Mediterranean Diet Adherence Screener (MEDAS) questionnaire Katrin Hebestreit, Maryam Yahiaoui‐Doktor, Christoph Engel, BMC Cancer	2017	139

Page 1